TY - JOUR
T1 - A protocol for the Hearing impairment in Adults
T2 - A Longitudinal Outcomes Study (HALOS)
AU - Tang, Diana
AU - Tran, Yvonne
AU - McMahon, Catherine
AU - Turner, Jessica
AU - Amin, Janaki
AU - Sinha, Kompal
AU - Alam, Mohammad Nure
AU - Wuthrich, Viviana
AU - Sherman, Kerry A.
AU - Garcia, Patrick
AU - Mitchell, Rebecca
AU - Braithwaite, Jeffrey
AU - Leigh, Greg
AU - Lim, Shermin
AU - Shekhawat, Giriraj Singh
AU - Rapport, Frances
AU - Ferguson, Melanie
AU - Gopinath, Bamini
PY - 2023/3/16
Y1 - 2023/3/16
N2 - Background: Often considered an "invisible disability", hearing loss is one of the most prevalent chronic diseases and the third leading cause for years lived with disability worldwide. Hearing loss has substantial impacts on communication, psychological wellbeing, social connectedness, cognition, quality of life, and economic independence. The Hearing impairment in Adults: A Longitudinal Outcomes Study (HALOS) aims to evaluate the: (1) impacts of hearing devices (hearing aids and/or cochlear implants), (2) differences in timing of these interventions and in long-Term outcomes between hearing aid and cochlear implant users, and (3) cost-effectiveness of early intervention for adult-onset hearing loss among hearing device users. Materials and methods: HALOS is a mixed-methods study collecting cross-sectional and longitudinal data on health and social outcomes from 908 hearing aid and/or cochlear implant users aged 40 years, recruited from hearing service providers across Australia. The quantitative component will involve an online survey at baseline (time of recruitment), 24-months, and 48-months and will collect audiological, health, psychosocial, functional and employment outcomes using validated instruments. The qualitative component will be conducted in a subset of participants at baseline and involve semi-structured interviews to understand the patient journey and perspectives on the Australian hearing service model. Ethics: This study has been approved by the Macquarie University Human Research Ethics Committee (ID: 11262) and Southern Adelaide Local Health Network (ID: LNR/22/SAC/88). Dissemination of results: Study findings will be disseminated to participants via a onepage summary, and to the public through publications in peer-reviewed journals and presentations at conferences.Trial registration
Australia New Zealand Clinical Trial Registry (ANZCTR) registration number:
ACTRN12622000752763.
AB - Background: Often considered an "invisible disability", hearing loss is one of the most prevalent chronic diseases and the third leading cause for years lived with disability worldwide. Hearing loss has substantial impacts on communication, psychological wellbeing, social connectedness, cognition, quality of life, and economic independence. The Hearing impairment in Adults: A Longitudinal Outcomes Study (HALOS) aims to evaluate the: (1) impacts of hearing devices (hearing aids and/or cochlear implants), (2) differences in timing of these interventions and in long-Term outcomes between hearing aid and cochlear implant users, and (3) cost-effectiveness of early intervention for adult-onset hearing loss among hearing device users. Materials and methods: HALOS is a mixed-methods study collecting cross-sectional and longitudinal data on health and social outcomes from 908 hearing aid and/or cochlear implant users aged 40 years, recruited from hearing service providers across Australia. The quantitative component will involve an online survey at baseline (time of recruitment), 24-months, and 48-months and will collect audiological, health, psychosocial, functional and employment outcomes using validated instruments. The qualitative component will be conducted in a subset of participants at baseline and involve semi-structured interviews to understand the patient journey and perspectives on the Australian hearing service model. Ethics: This study has been approved by the Macquarie University Human Research Ethics Committee (ID: 11262) and Southern Adelaide Local Health Network (ID: LNR/22/SAC/88). Dissemination of results: Study findings will be disseminated to participants via a onepage summary, and to the public through publications in peer-reviewed journals and presentations at conferences.Trial registration
Australia New Zealand Clinical Trial Registry (ANZCTR) registration number:
ACTRN12622000752763.
KW - Hearing loss
KW - Mixed-methods study
KW - Cross-sectional data
KW - Longitudinal data
KW - Health outcomes
KW - Social outcomes
UR - http://www.scopus.com/inward/record.url?scp=85150266502&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0283171
DO - 10.1371/journal.pone.0283171
M3 - Article
C2 - 36928424
AN - SCOPUS:85150266502
SN - 1932-6203
VL - 18
JO - PLoS One
JF - PLoS One
IS - 3
M1 - e0283171
ER -